The MyoVista® signal processed ECG (spECG™) Cardiac Testing device introduces breakthrough technology that is designed to assist in the early detection of heart disease. The MyoVista® spECG™  is an innovative advancement for low-cost electrocardiographic testing. It uses advanced signal processing that features the use of wavelet mathematics. Wavelet mathematics are used in many different industries today since new potentially valuable information is provided from spectral analysis of a signal. MyoVista spECG™ technology benefits from more than 10 years of progressive research and development.